Clear objectives, proper planning, change management, adequate resources, and ongoing maintenance can lead to better outcomes for your LIMS...
This post explores the steps that can sometimes trap therapeutic discovery teams and CROs on the path of building their own bioregistry without...
Advances in artificial intelligence (AI) and machine learning (ML) have shown significant promise is in the de novo generation of therapeutic...
Artificial intelligence (AI) and machine learning (ML) are playing increasingly significant roles in the field of drug discovery.
It has never been more important to organize, standardize, and centralize data collection in the pursuit of new medicines.
Phage display has become an invaluable tool for the discovery of novel therapeutic agents, including nanobodies.
NGS offers an approach for identifying and extracting variable domain heavy-chain (VHH) regions from camelid B-cells.
In the fight against infectious diseases, scientists are continually seeking to outsmart pathogens. One such strategy involves the use of nanobodies.
In the search for new therapies that can treat a wide variety of neurodegenerative diseases, scientists are exploring the potential of nanobodies.
StackWave Affinity v16 Announcement - Next Generation Sequencing